Not exact matches
Although she never received any medical or surgical treatment for the deadly cancer invading her
lungs, six weeks after starting psychosynthesis, her
tumors began to
shrink.
In one, a liver and armpit
tumor that had developed from spreading melanoma cells
shrank, and in the other a
lung tumor disappeared.
An anti-PD-1 antibody developed by Bristol - Myers Squibb generates excitement with results from a phase I trial showing that, among 236 patients with various types of cancer, the treatment
shrank tumors in 28 percent of melanoma patients, 30 percent of patients with kidney cancer, and 18 percent of patients with advanced non-small cell
lung cancer.